As far as TWF,
REGN went up a couple buck and down 3, INO, Kerx, acad, pretty flat. Did not bother checking others. Mannkind will be walking upwards now. Rising bottom.
I really hope that something additional materializes in the deal department with Medtronic as this makes a lot of sense as it relates to Mnkd's website, "Mannkind Technologies" I am betting that all their Technosphere app's, many of their present, any future and pending patents would go there would fit under that roof. The slip of tongue by John Tyler about this could be the cat-out-of-the-bag. Let's hope.
I am not sure how shareholders would be compensated in a twofold deal as I believe the present deal with Sanofi would more or less stay intact.
Official putz commentator11, Actually this is on going. But your selective putz commentator is invariant when it comes to siding with the "dark side". Soon "you're" will be in the poor house. Your dimwitted posts are invariant.
Why is ymb police removing this information. Is this a conspiracy against American citizens? Have they become cows for the manipulators?
This is what the YMB trolls were espousing on REGN board back around March 29, 2003 after a partnership with NOVO. PPS dropped from 25 down 6.5. Trolls were saying REGN was toast, over finished. Today, they are around $400.00 troll boy.
Considering Kevin's recent find from the North Carolina teachers insurance approving Afrezza as a preventative medicine, pfg looks more like the savant here.
Basically I am thinking pain meds.
In an exemplary embodiment herewith, the method for treating pain comprises providing to a subject an inhalable pharmaceutical composition comprising a dry powder comprising one or more receptor agonist peptides. The receptor agonists can be, for example, aipha-MSH receptor agonists, or opioid receptor agonists, or the like. In one embodiment, the dry powder comprises a diketopiperazine, including, A/-substituted-3,6-aminoaikyl-2,5- diketopiperazines. Sn this and other embodiments, the diketopiperazine can be 2,5-diketo-3,6- di(4-X-aminobutyl)piperazine wherein X-QH is a dicarboxyiic acid, for example, X may be fumaryl, succinyi, giutaryi, maieyl, maiony!, oxaiyi, or a pharmaceutically acceptable salt thereof.
I believe you right for now on SA. It would be easier to produce in France with the Amph plant which is already approved for insulin for afrezza. But it is good to see the new plant in SA nevertheless. It means they have a pretty good relationship there. (SNY that is.)
Diketopiperazines, in addition to making aerodynamica!iy suitable microparticles, dissolve rapidly at physiologic pH thereby releasing the active agent for absorption into the circulation. Diketopiperazines can be formed into particles that incorporate a drug or particles onto which a drug can be adsorbed. The combination of a drug and a diketopiperazine can impart improved drug stability. These particles can be administered by various routes of administration. As dry powders these particles can be delivered by inhalation to specific areas of the respiratory system, depending on particle size. Additionally, the particles can be made small enough for incorporation into an intravenous suspension dosage form. Oral delivery is also possible with the particles incorporated into suspensions, tablets or capsules...
Percent respirabie fraction per fill (%RF/Fill): As used herein "%RF/Fii!" refers to the amount of powder particles emitted from an inhaler, or drug delivery system, which particles are of size in the respirabie range and can be smaller than 5.8 μπΊ, normalized by the total amount of powder filled info inhaler or drug delivery system. Sn some embodiments, the inhaler can be reusable comprising replaceable cartridges containing the dry powder, in other embodiments, the inhaler is manufactured containing the formulation for single use.
 Dry powder formulations of the inhalation systems can comprise active agents for the treatment of acute or chronic pain. In one embodiment, the dry powder formulation can be used for treating pain directly or indirectly associated with central or peripheral nervous system involvement, including, for example, headaches such as migraines; post-operative pain, and pain associated with one or more diseases, including, but not limited to cancer, renal disease, immune disorders including, autoimmune disease, a peripheral neuropathy, a central neuropathy, a traumatic abnormality, a cerebral vascular accident, postoperative pain,
Matese, I apologize, I misinterpreted what you said. I have thin skin here as the barrage of anti mannkinders has taken its toll and I probably should just take a chill pill.